-
1
-
-
84872967522
-
Cancer statistics
-
2013. CA Cancer
-
Siegel, R.; Naishadham, D.; Jemal, A. Cancer statistics, 2013. CA Cancer J. Clin. 2013, 63, 11-30.
-
(2013)
J. Clin
, vol.63
, pp. 11-30
-
-
Siegel, R.1
Naishadham, D.2
Jemal, A.3
-
2
-
-
0043240182
-
Ovarian cancer: Strategies for overcoming resistance to chemotherapy
-
Agarwal, R.; Kaye, S.B. Ovarian cancer: Strategies for overcoming resistance to chemotherapy. Nat. Rev. Cancer 2003, 3, 502-516.
-
(2003)
Nat. Rev. Cancer
, vol.3
, pp. 502-516
-
-
Agarwal, R.1
Kaye, S.B.2
-
3
-
-
0034015340
-
Evaluation of plasma lysophospholipids for diagnostic significance using electrospray ionization mass spectrometry (ESI-MS) analyses
-
Xiao, Y.; Chen, Y.; Kennedy, A.W.; Belinson, J.; Xu, Y. Evaluation of plasma lysophospholipids for diagnostic significance using electrospray ionization mass spectrometry (ESI-MS) analyses. Ann. N. Y. Acad. Sci. 2000, 905, 242-259.
-
(2000)
Ann. N. Y. Acad. Sci
, vol.905
, pp. 242-259
-
-
Xiao, Y.1
Chen, Y.2
Kennedy, A.W.3
Belinson, J.4
Xu, Y.5
-
4
-
-
0032569235
-
Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers
-
Xu, Y.; Shen, Z.; Wiper, D.W.; Wu, M.; Morton, R.E.; Elson, P.; Kennedy, A.W.; Belinson, J.; Markman, M.; Casey, G. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA 1998, 280, 719-723.
-
(1998)
JAMA
, vol.280
, pp. 719-723
-
-
Xu, Y.1
Shen, Z.2
Wiper, D.W.3
Wu, M.4
Morton, R.E.5
Elson, P.6
Kennedy, A.W.7
Belinson, J.8
Markman, M.9
Casey, G.10
-
5
-
-
78149423097
-
Association of lipid metabolism with ovarian cancer
-
Tania, M.; Khan, M.A.; Song, Y. Association of lipid metabolism with ovarian cancer. Curr. Oncol. 2010, 17, 6-11.
-
(2010)
Curr. Oncol
, vol.17
, pp. 6-11
-
-
Tania, M.1
Khan, M.A.2
Song, Y.3
-
6
-
-
0030936232
-
Androgens stimulate fatty acid synthase in the human prostate cancer cell line lncap
-
Swinnen, J.V.; Esquenet, M.; Goossens, K.; Heyns, W.; Verhoeven, G. Androgens stimulate fatty acid synthase in the human prostate cancer cell line lncap. Cancer Res. 1997, 57, 1086-1090.
-
(1997)
Cancer Res
, vol.57
, pp. 1086-1090
-
-
Swinnen, J.V.1
Esquenet, M.2
Goossens, K.3
Heyns, W.4
Verhoeven, G.5
-
7
-
-
0031007392
-
Increased expression of fatty acid synthase (oa-519) in ovarian neoplasms predicts shorter survival
-
Gansler, T.S.; Hardman, W., 3rd; Hunt, D.A.; Schaffel, S.; Hennigar, R.A. Increased expression of fatty acid synthase (oa-519) in ovarian neoplasms predicts shorter survival. Hum. Pathol. 1997, 28, 686-692.
-
(1997)
Hum. Pathol
, vol.28
, pp. 686-692
-
-
Gansler, T.S.1
Hardman III, W.2
Hunt, D.A.3
Schaffel, S.4
Hennigar, R.A.5
-
8
-
-
0029971427
-
Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer
-
Pizer, E.S.; Wood, F.D.; Heine, H.S.; Romantsev, F.E.; Pasternack, G.R.; Kuhajda, F.P. Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer. Cancer Res. 1996, 56, 1189-1193.
-
(1996)
Cancer Res
, vol.56
, pp. 1189-1193
-
-
Pizer, E.S.1
Wood, F.D.2
Heine, H.S.3
Romantsev, F.E.4
Pasternack, G.R.5
Kuhajda, F.P.6
-
9
-
-
69449099939
-
-
Inhibition of stearoylcoa desaturase-1 inactivates acetyl-coa carboxylase and impairs proliferation in cancer cells: Role of ampk, doi:10.1371/journal.pone.0006812
-
Scaglia, N.; Chisholm, J.W.; Igal, R.A. Inhibition of stearoylcoa desaturase-1 inactivates acetyl-coa carboxylase and impairs proliferation in cancer cells: Role of ampk. PLoS One 2009, 4, doi:10.1371/journal.pone.0006812
-
(2009)
PLoS One
, pp. 4
-
-
Scaglia, N.1
Chisholm, J.W.2
Igal, R.A.3
-
10
-
-
0036385719
-
Activation of fatty acid synthesis during neoplastic transformation: Role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase
-
Yang, Y.A.; Han, W.F.; Morin, P.J.; Chrest, F.J.; Pizer, E.S. Activation of fatty acid synthesis during neoplastic transformation: Role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Exp. Cell Res. 2002, 279, 80-90.
-
(2002)
Exp. Cell Res
, vol.279
, pp. 80-90
-
-
Yang, Y.A.1
Han, W.F.2
Morin, P.J.3
Chrest, F.J.4
Pizer, E.S.5
-
11
-
-
33744808464
-
Acetyl-coa carboxylase alpha is essential to breast cancer cell survival
-
Chajes, V.; Cambot, M.; Moreau, K.; Lenoir, G.M.; Joulin, V. Acetyl-coa carboxylase alpha is essential to breast cancer cell survival. Cancer Res. 2006, 66, 5287-5294.
-
(2006)
Cancer Res
, vol.66
, pp. 5287-5294
-
-
Chajes, V.1
Cambot, M.2
Moreau, K.3
Lenoir, G.M.4
Joulin, V.5
-
12
-
-
54249161009
-
-
Atp citrate lyase: Activation and therapeutic implications in non-small cell lung cancer
-
Migita, T.; Narita, T.; Nomura, K.; Miyagi, E.; Inazuka, F.; Matsuura, M.; Ushijima, M.; Mashima, T.; Seimiya, H.; Satoh, Y.; et al. Atp citrate lyase: Activation and therapeutic implications in non-small cell lung cancer. Cancer Res. 2008, 68, 8547-8554.
-
(2008)
Cancer Res
, vol.68
, pp. 8547-8554
-
-
Migita, T.1
Narita, T.2
Nomura, K.3
Miyagi, E.4
Inazuka, F.5
Matsuura, M.6
Ushijima, M.7
Mashima, T.8
Seimiya, H.9
Satoh, Y.10
-
13
-
-
0034715909
-
Sterol regulatory element-binding protein-1 participates in the regulation of fatty acid synthase expression in colorectal neoplasia
-
Li, J.N.; Mahmoud, M.A.; Han, W.F.; Ripple, M.; Pizer, E.S. Sterol regulatory element-binding protein-1 participates in the regulation of fatty acid synthase expression in colorectal neoplasia. Exp. Cell Res. 2000, 261, 159-165.
-
(2000)
Exp. Cell Res
, vol.261
, pp. 159-165
-
-
Li, J.N.1
Mahmoud, M.A.2
Han, W.F.3
Ripple, M.4
Pizer, E.S.5
-
14
-
-
79952280229
-
P53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase
-
Jiang, P.; Du, W.; Wang, X.; Mancuso, A.; Gao, X.; Wu, M.; Yang, X. P53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nat. Cell Biol. 2011, 13, 310-316.
-
(2011)
Nat. Cell Biol
, vol.13
, pp. 310-316
-
-
Jiang, P.1
Du, W.2
Wang, X.3
Mancuso, A.4
Gao, X.5
Wu, M.6
Yang, X.7
-
15
-
-
33745918951
-
Tigar, a p53-inducible regulator of glycolysis and apoptosis
-
Bensaad, K.; Tsuruta, A.; Selak, M.A.; Vidal, M.N.; Nakano, K.; Bartrons, R.; Gottlieb, E.; Vousden, K.H. Tigar, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006, 126, 107-120.
-
(2006)
Cell
, vol.126
, pp. 107-120
-
-
Bensaad, K.1
Tsuruta, A.2
Selak, M.A.3
Vidal, M.N.4
Nakano, K.5
Bartrons, R.6
Gottlieb, E.7
Vousden, K.H.8
-
16
-
-
77952212178
-
Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function
-
Hu, W.; Zhang, C.; Wu, R.; Sun, Y.; Levine, A.; Feng, Z. Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc. Natl. Acad. Sci. USA 2010, 107, 7455-7460.
-
(2010)
Proc. Natl. Acad. Sci. USA
, vol.107
, pp. 7455-7460
-
-
Hu, W.1
Zhang, C.2
Wu, R.3
Sun, Y.4
Levine, A.5
Feng, Z.6
-
17
-
-
84874949245
-
Dysregulated lipid metabolism in cancer
-
Zhang, F.; Du, G. Dysregulated lipid metabolism in cancer. World J. Biol. Chem. 2012, 3, 167-174.
-
(2012)
J. Biol. Chem
, vol.3
, pp. 167-174
-
-
Zhang, F.1
Du, G.2
-
18
-
-
0032931075
-
Prospective study of diet and ovarian cancer
-
Kushi, L.H.; Mink, P.J.; Folsom, A.R.; Anderson, K.E.; Zheng, W.; Lazovich, D.; Sellers, T.A. Prospective study of diet and ovarian cancer. Am. J. Epidemiol. 1999, 149, 21-31.
-
(1999)
Am. J. Epidemiol
, vol.149
, pp. 21-31
-
-
Kushi, L.H.1
Mink, P.J.2
Folsom, A.R.3
Anderson, K.E.4
Zheng, W.5
Lazovich, D.6
Sellers, T.A.7
-
19
-
-
0023619726
-
Dietary factors and the risk of epithelial ovarian cancer
-
La Vecchia, C.; Decarli, A.; Negri, E.; Parazzini, F.; Gentile, A.; Cecchetti, G.; Fasoli, M.; Franceschi, S. Dietary factors and the risk of epithelial ovarian cancer. J. Natl. Cancer Inst. 1987, 79, 663-669.
-
(1987)
J. Natl. Cancer Inst.
, vol.79
, pp. 663-669
-
-
la Vecchia, C.1
Decarli, A.2
Negri, E.3
Parazzini, F.4
Gentile, A.5
Cecchetti, G.6
Fasoli, M.7
Franceschi, S.8
-
20
-
-
4444315616
-
A case-control study of diet and the risk of ovarian cancer
-
Cancer Epidemiol
-
Pan, S.Y.; Ugnat, A.M.; Mao, Y.; Wen, S.W.; Johnson, K.C. A case-control study of diet and the risk of ovarian cancer. Cancer Epidemiol. Biomarkers Prev. 2004, 13, 1521-1527.
-
(2004)
Biomarkers Prev
, vol.13
, pp. 1521-1527
-
-
Pan, S.Y.1
Ugnat, A.M.2
Mao, Y.3
Wen, S.W.4
Johnson, K.C.5
-
21
-
-
0027989889
-
Dietary fat intake and risk of epithelial ovarian cancer
-
Risch, H.A.; Jain, M.; Marrett, L.D.; Howe, G.R. Dietary fat intake and risk of epithelial ovarian cancer. J. Natl. Cancer Inst. 1994, 86, 1409-1415.
-
(1994)
Natl. Cancer Inst
, vol.86
, pp. 1409-1415
-
-
Risch, H.A.1
Jain, M.2
Marrett, L.D.3
Howe, G.R.4
-
22
-
-
0032477328
-
-
Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone
-
Risch, H.A. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J. Natl. Cancer Inst. 1998, 90, 1774-1786.
-
(1998)
J. Natl. Cancer Inst
, vol.90
, pp. 1774-1786
-
-
Risch, H.A.1
-
23
-
-
34748912615
-
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
-
Menendez, J.A.; Lupu, R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat. Rev. Cancer 2007, 7, 763-777.
-
(2007)
Nat. Rev. Cancer
, vol.7
, pp. 763-777
-
-
Menendez, J.A.1
Lupu, R.2
-
24
-
-
81255157465
-
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
-
Nieman, K.M.; Kenny, H.A.; Penicka, C.V.; Ladanyi, A.; Buell-Gutbrod, R.; Zillhardt, M.R.; Romero, I.L.; Carey, M.S.; Mills, G.B.; Hotamisligil, G.S.; et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat. Med. 2011, 17, 1498-1503.
-
(2011)
Nat. Med
, vol.17
, pp. 1498-1503
-
-
Nieman, K.M.1
Kenny, H.A.2
Penicka, C.V.3
Ladanyi, A.4
Buell-Gutbrod, R.5
Zillhardt, M.R.6
Romero, I.L.7
Carey, M.S.8
Mills, G.B.9
Hotamisligil, G.S.10
-
25
-
-
77953527951
-
Expression of fatty acid synthase depends on nac1 and is associated with recurrent ovarian serous carcinomas
-
285191
-
Ueda, S.M.; Yap, K.L.; Davidson, B.; Tian, Y.; Murthy, V.; Wang, T.L.; Visvanathan, K.; Kuhajda, F.P.; Bristow, R.E.; Zhang, H.; et al. Expression of fatty acid synthase depends on nac1 and is associated with recurrent ovarian serous carcinomas. J. Oncol. 2010, 2010, 285191.
-
(2010)
J. Oncol
, vol.2010
-
-
Ueda, S.M.1
Yap, K.L.2
Davidson, B.3
Tian, Y.4
Murthy, V.5
Wang, T.L.6
Visvanathan, K.7
Kuhajda, F.P.8
Bristow, R.E.9
Zhang, H.10
-
26
-
-
0344838439
-
Fatty acid synthase drives the synthesis of phospholipids partitioning into detergent-resistant membrane microdomains
-
Swinnen, J.V.; van Veldhoven, P.P.; Timmermans, L.; de Schrijver, E.; Brusselmans, K.; Vanderhoydonc, F.; van de Sande, T.; Heemers, H.; Heyns, W.; Verhoeven, G. Fatty acid synthase drives the synthesis of phospholipids partitioning into detergent-resistant membrane microdomains. Biochem. Biophys. Res. Commun. 2003, 302, 898-903.
-
(2003)
Biochem. BiophysRes. Commun
, vol.302
, pp. 898-903
-
-
Swinnen, J.V.1
van Veldhoven, P.P.2
Timmermans, L.3
de Schrijver, E.4
Brusselmans, K.5
Vanderhoydonc, F.6
van de Sande, T.7
Heemers, H.8
Heyns, W.9
Verhoeven, G.10
-
27
-
-
33847034466
-
Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells
-
Little, J.L.; Wheeler, F.B.; Fels, D.R.; Koumenis, C.; Kridel, S.J. Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells. Cancer Res. 2007, 67, 1262-1269.
-
(2007)
Cancer Res
, vol.67
, pp. 1262-1269
-
-
Little, J.L.1
Wheeler, F.B.2
Fels, D.R.3
Koumenis, C.4
Kridel, S.J.5
-
28
-
-
0242694902
-
Fatty acid synthase inhibition triggers apoptosis during s phase in human cancer cells
-
Zhou, W.; Simpson, P.J.; McFadden, J.M.; Townsend, C.A.; Medghalchi, S.M.; Vadlamudi, A.; Pinn, M.L.; Ronnett, G.V.; Kuhajda, F.P. Fatty acid synthase inhibition triggers apoptosis during s phase in human cancer cells. Cancer Res. 2003, 63, 7330-7337.
-
(2003)
Cancer Res
, vol.63
, pp. 7330-7337
-
-
Zhou, W.1
Simpson, P.J.2
McFadden, J.M.3
Townsend, C.A.4
Medghalchi, S.M.5
Vadlamudi, A.6
Pinn, M.L.7
Ronnett, G.V.8
Kuhajda, F.P.9
-
29
-
-
34248211595
-
Fatty acid synthase inhibition activates amp-activated protein kinase in skov3 human ovarian cancer cells
-
Zhou, W.; Han, W.F.; Landree, L.E.; Thupari, J.N.; Pinn, M.L.; Bililign, T.; Kim, E.K.; Vadlamudi, A.; Medghalchi, S.M.; El Meskini, R.; et al. Fatty acid synthase inhibition activates amp-activated protein kinase in skov3 human ovarian cancer cells. Cancer Res. 2007, 67, 2964-2971.
-
(2007)
Cancer Res
, vol.67
, pp. 2964-2971
-
-
Zhou, W.1
Han, W.F.2
Landree, L.E.3
Thupari, J.N.4
Pinn, M.L.5
Bililign, T.6
Kim, E.K.7
Vadlamudi, A.8
Medghalchi, S.M.9
Meskini, R.10
-
30
-
-
84863727675
-
Fatty acid synthase expression associated with nac1 is a potential therapeutic target in ovarian clear cell carcinomas
-
Rahman, M.T.; Nakayama, K.; Rahman, M.; Katagiri, H.; Katagiri, A.; Ishibashi, T.; Ishikawa, M.; Iida, K.; Nakayama, N.; Otsuki, Y.; et al. Fatty acid synthase expression associated with nac1 is a potential therapeutic target in ovarian clear cell carcinomas. Br. J. Cancer 2012, 107, 300-307.
-
(2012)
Br. J. Cancer
, vol.107
, pp. 300-307
-
-
Rahman, M.T.1
Nakayama, K.2
Rahman, M.3
Katagiri, H.4
Katagiri, A.5
Ishibashi, T.6
Ishikawa, M.7
Iida, K.8
Nakayama, N.9
Otsuki, Y.10
-
31
-
-
84055207483
-
Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer
-
Tomek, K.; Wagner, R.; Varga, F.; Singer, C.F.; Karlic, H.; Grunt, T.W. Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer. Mol. Cancer Res. 2011, 9, 1767-1779.
-
(2011)
Mol. Cancer Res
, vol.9
, pp. 1767-1779
-
-
Tomek, K.1
Wagner, R.2
Varga, F.3
Singer, C.F.4
Karlic, H.5
Grunt, T.W.6
-
32
-
-
0023616007
-
Phospholipid metabolism in cancer cells monitored by 31p nmr spectroscopy
-
Daly, P.F.; Lyon, R.C.; Faustino, P.J.; Cohen, J.S. Phospholipid metabolism in cancer cells monitored by 31p nmr spectroscopy. J. Biol. Chem. 1987, 262, 14875-14878.
-
(1987)
J. Biol. Chem
, vol.262
, pp. 14875-14878
-
-
Daly, P.F.1
Lyon, R.C.2
Faustino, P.J.3
Cohen, J.S.4
-
33
-
-
2442658976
-
Lysophospholipid g protein-coupled receptors
-
Anliker, B.; Chun, J. Lysophospholipid g protein-coupled receptors. J. Biol. Chem. 2004, 279, 20555-20558.
-
(2004)
J. Biol. Chem
, vol.279
, pp. 20555-20558
-
-
Anliker, B.1
Chun, J.2
-
34
-
-
0038152846
-
Identification of p2y9/gpr23 as a novel g protein-coupled receptor for lysophosphatidic acid, structurally distant from the edg family
-
Noguchi, K.; Ishii, S.; Shimizu, T. Identification of p2y9/gpr23 as a novel g protein-coupled receptor for lysophosphatidic acid, structurally distant from the edg family. J. Biol. Chem. 2003, 278, 25600-25606.
-
(2003)
J. Biol. Chem
, vol.278
, pp. 25600-25606
-
-
Noguchi, K.1
Ishii, S.2
Shimizu, T.3
-
35
-
-
33747685338
-
-
Gpr92 as a new g12/13- and gq-coupled lysophosphatidic acid receptor that increases camp, lpa5
-
Lee, C.W.; Rivera, R.; Gardell, S.; Dubin, A.E.; Chun, J. Gpr92 as a new g12/13- and gq-coupled lysophosphatidic acid receptor that increases camp, lpa5. J. Biol. Chem. 2006, 281, 23589-23597.
-
(2006)
J. Biol. Chem
, vol.281
, pp. 23589-23597
-
-
Lee, C.W.1
Rivera, R.2
Gardell, S.3
Dubin, A.E.4
Chun, J.5
-
36
-
-
67650522890
-
-
Yanagida, K.; Masago, K.; Nakanishi, H.; Kihara, Y.; Hamano, F.; Tajima, Y.; Taguchi, R.; Shimizu, T.; Ishii, S. Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/lpa6. J. Biol. Chem. 2009, 284, 17731-17741.
-
(2009)
Biol. Chem
, vol.284
, pp. 17731-17741
-
-
Yanagida, K.1
Masago, K.2
Nakanishi, H.3
Kihara, Y.4
Hamano, F.5
Tajima, Y.6
Taguchi, R.7
Shimizu, T.8
Ishii, S.9
-
37
-
-
77949526409
-
-
Lpa receptors: Subtypes and biological actions
-
Choi, J.W.; Herr, D.R.; Noguchi, K.; Yung, Y.C.; Lee, C.W.; Mutoh, T.; Lin, M.E.; Teo, S.T.; Park, K.E.; Mosley, A.N.; et al. Lpa receptors: Subtypes and biological actions. Annu. Rev. Pharmacol. Toxicol. 2010, 50, 157-186.
-
(2010)
Annu. Rev. Pharmacol. Toxicol
, vol.50
, pp. 157-186
-
-
Choi, J.W.1
Herr, D.R.2
Noguchi, K.3
Yung, Y.C.4
Lee, C.W.5
Mutoh, T.6
Lin, M.E.7
Teo, S.T.8
Park, K.E.9
Mosley, A.N.10
-
38
-
-
84864078672
-
Lysophosphatidic acid activates lipogenic pathways and de novo lipid synthesis in ovarian cancer cells
-
Mukherjee, A.; Wu, J.; Barbour, S.; Fang, X. Lysophosphatidic acid activates lipogenic pathways and de novo lipid synthesis in ovarian cancer cells. J. Biol. Chem. 2012, 287, 24990-25000.
-
(2012)
Biol. Chem
, vol.287
, pp. 24990-25000
-
-
Mukherjee, A.1
Wu, J.2
Barbour, S.3
Fang, X.4
-
39
-
-
56749151299
-
Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells
-
Yu, S.; Murph, M.M.; Lu, Y.; Liu, S.; Hall, H.S.; Liu, J.; Stephens, C.; Fang, X.; Mills, G.B. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells. J. Natl. Cancer Inst. 2008, 100, 1630-1642.
-
(2008)
J. Natl. Cancer Inst
, vol.100
, pp. 1630-1642
-
-
Yu, S.1
Murph, M.M.2
Lu, Y.3
Liu, S.4
Hall, H.S.5
Liu, J.6
Stephens, C.7
Fang, X.8
Mills, G.B.9
-
40
-
-
33645525087
-
Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells
-
Ren, J.; Xiao, Y.J.; Singh, L.S.; Zhao, X.; Zhao, Z.; Feng, L.; Rose, T.M.; Prestwich, G.D.; Xu, Y. Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells. Cancer Res. 2006, 66, 3006-3014.
-
(2006)
Cancer Res
, vol.66
, pp. 3006-3014
-
-
Ren, J.1
Xiao, Y.J.2
Singh, L.S.3
Zhao, X.4
Zhao, Z.5
Feng, L.6
Rose, T.M.7
Prestwich, G.D.8
Xu, Y.9
-
41
-
-
3142660497
-
Lysophospholipids are potential biomarkers of ovarian cancer
-
ancer Epidemiol
-
Sutphen, R.; Xu, Y.; Wilbanks, G.D.; Fiorica, J.; Grendys, E.C., Jr.; LaPolla, J.P.; Arango, H.; Hoffman, M.S.; Martino, M.; Wakeley, K.; et al. Lysophospholipids are potential biomarkers of ovarian cancer. Cancer Epidemiol. Biomarkers Prev. 2004, 13, 1185-1191.
-
(2004)
Biomarkers Prev
, vol.13
, pp. 1185-1191
-
-
Sutphen, R.1
Xu, Y.2
Wilbanks, G.D.3
Fiorica, J.4
Grendys Jr., E.C.5
Lapolla, J.P.6
Arango, H.7
Hoffman, M.S.8
Martino, M.9
Wakeley, K.10
-
42
-
-
0028871499
-
Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients
-
Xu, Y.; Gaudette, D.C.; Boynton, J.D.; Frankel, A.; Fang, X.J.; Sharma, A.; Hurteau, J.; Casey, G.; Goodbody, A.; Mellors, A.; et al. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. Clin. Cancer Res. 1995, 1, 1223-1232.
-
(1995)
Clin. Cancer Res
, vol.1
, pp. 1223-1232
-
-
Xu, Y.1
Gaudette, D.C.2
Boynton, J.D.3
Frankel, A.4
Fang, X.J.5
Sharma, A.6
Hurteau, J.7
Casey, G.8
Goodbody, A.9
Mellors, A.10
-
43
-
-
0037134949
-
Plasma lysophosphatidic acid concentration and ovarian cancer
-
Baker, D.L.; Morrison, P.; Miller, B.; Riely, C.A.; Tolley, B.; Westermann, A.M.; Bonfrer, J.M.; Bais, E.; Moolenaar, W.H.; Tigyi, G. Plasma lysophosphatidic acid concentration and ovarian cancer. JAMA 2002, 287, 3081-3082.
-
(2002)
JAMA
, vol.287
, pp. 3081-3082
-
-
Baker, D.L.1
Morrison, P.2
Miller, B.3
Riely, C.A.4
Tolley, B.5
Westermann, A.M.6
Bonfrer, J.M.7
Bais, E.8
Moolenaar, W.H.9
Tigyi, G.10
-
44
-
-
84864740329
-
Elevated and secreted phospholipase a(2) activities as new potential therapeutic targets in human epithelial ovarian cancer
-
Cai, Q.; Zhao, Z.; Antalis, C.; Yan, L.; Del Priore, G.; Hamed, A.H.; Stehman, F.B.; Schilder, J.M.; Xu, Y. Elevated and secreted phospholipase a(2) activities as new potential therapeutic targets in human epithelial ovarian cancer. FASEB J. 2012, 26, 3306-3320.
-
(2012)
FASEB J
, vol.26
, pp. 3306-3320
-
-
Cai, Q.1
Zhao, Z.2
Antalis, C.3
Yan, L.4
Del Priore, G.5
Hamed, A.H.6
Stehman, F.B.7
Schilder, J.M.8
Xu, Y.9
-
45
-
-
0032712996
-
Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells
-
Pustilnik, T.B.; Estrella, V.; Wiener, J.R.; Mao, M.; Eder, A.; Watt, M.A.; Bast, R.C., Jr.; Mills, G.B. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells. Clin. Cancer Res. 1999, 5, 3704-3710.
-
(1999)
Clin. Cancer Res
, vol.5
, pp. 3704-3710
-
-
Pustilnik, T.B.1
Estrella, V.2
Wiener, J.R.3
Mao, M.4
Eder, A.5
Watt, M.A.6
Bast Jr., R.C.7
Mills, G.B.8
-
46
-
-
43449112380
-
-
Inhibition of lysophosphatidic acid receptor-2 expression by RNA interference decreases lysophosphatidic acid-induced urokinase plasminogen activator activation, cell invasion, and migration in ovarian cancer skov-3 cells
-
Wang, G.L.; Wen, Z.Q.; Xu, W.P.; Wang, Z.Y.; Du, X.L.; Wang, F. Inhibition of lysophosphatidic acid receptor-2 expression by RNA interference decreases lysophosphatidic acid-induced urokinase plasminogen activator activation, cell invasion, and migration in ovarian cancer skov-3 cells. Croat. Med. J. 2008, 49, 175-181.
-
(2008)
Croat. Med. J
, vol.49
, pp. 175-181
-
-
Wang, G.L.1
Wen, Z.Q.2
Xu, W.P.3
Wang, Z.Y.4
Du, X.L.5
Wang, F.6
-
47
-
-
0742307276
-
Plasminogen fragmentation and increased production of extracellular matrix-degrading proteinases are associated with serous epithelial ovarian cancer progression
-
Murthi, P.; Barker, G.; Nowell, C.J.; Rice, G.E.; Baker, M.S.; Kalionis, B.; Quinn, M.A. Plasminogen fragmentation and increased production of extracellular matrix-degrading proteinases are associated with serous epithelial ovarian cancer progression. Gynecol. Oncol. 2004, 92, 80-88.
-
(2004)
Gynecol. Oncol
, vol.92
, pp. 80-88
-
-
Murthi, P.1
Barker, G.2
Nowell, C.J.3
Rice, G.E.4
Baker, M.S.5
Kalionis, B.6
Quinn, M.A.7
-
48
-
-
0035300534
-
Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells
-
Fishman, D.A.; Liu, Y.; Ellerbroek, S.M.; Stack, M.S. Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells. Cancer Res. 2001, 61, 3194-3199.
-
(2001)
Cancer Res
, vol.61
, pp. 3194-3199
-
-
Fishman, D.A.1
Liu, Y.2
Ellerbroek, S.M.3
Stack, M.S.4
-
49
-
-
84867083414
-
The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion
-
Jeong, K.J.; Park, S.Y.; Cho, K.H.; Sohn, J.S.; Lee, J.; Kim, Y.K.; Kang, J.; Park, C.G.; Han, J.W.; Lee, H.Y. The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion. Oncogene 2012, 31, 4279-4289.
-
(2012)
Oncogene
, vol.31
, pp. 4279-4289
-
-
Jeong, K.J.1
Park, S.Y.2
Cho, K.H.3
Sohn, J.S.4
Lee, J.5
Kim, Y.K.6
Kang, J.7
Park, C.G.8
Han, J.W.9
Lee, H.Y.10
-
50
-
-
0035897531
-
Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells
-
Hu, Y.L.; Tee, M.K.; Goetzl, E.J.; Auersperg, N.; Mills, G.B.; Ferrara, N.; Jaffe, R.B. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells. J. Natl. Cancer Inst. 2001, 93, 762-768.
-
(2001)
J. Natl. Cancer Inst
, vol.93
, pp. 762-768
-
-
Hu, Y.L.1
Tee, M.K.2
Goetzl, E.J.3
Auersperg, N.4
Mills, G.B.5
Ferrara, N.6
Jaffe, R.B.7
-
51
-
-
40949146034
-
Positive feedback between vascular endothelial growth factor-a and autotaxin in ovarian cancer cells
-
Ptaszynska, M.M.; Pendrak, M.L.; Bandle, R.W.; Stracke, M.L.; Roberts, D.D. Positive feedback between vascular endothelial growth factor-a and autotaxin in ovarian cancer cells. Mol. Cancer Res. 2008, 6, 352-363.
-
(2008)
Mol. Cancer Res
, vol.6
, pp. 352-363
-
-
Ptaszynska, M.M.1
Pendrak, M.L.2
Bandle, R.W.3
Stracke, M.L.4
Roberts, D.D.5
-
52
-
-
59449108691
-
-
Sp-1 and c-myc mediate lysophosphatidic acid-induced expression of vascular endothelial growth factor in ovarian cancer cells via a hypoxia-inducible factor-1-independent mechanism
-
Song, Y.; Wu, J.; Oyesanya, R.A.; Lee, Z.; Mukherjee, A.; Fang, X. Sp-1 and c-myc mediate lysophosphatidic acid-induced expression of vascular endothelial growth factor in ovarian cancer cells via a hypoxia-inducible factor-1-independent mechanism. Clin. Cancer Res. 2009, 15, 492-501.
-
(2009)
Clin. Cancer Res
, vol.15
, pp. 492-501
-
-
Song, Y.1
Wu, J.2
Oyesanya, R.A.3
Lee, Z.4
Mukherjee, A.5
Fang, X.6
-
53
-
-
0033864069
-
Y-27632, an inhibitor of rho-associated protein kinase, suppresses tumor cell invasion via regulation of focal adhesion and focal adhesion kinase
-
Imamura, F.; Mukai, M.; Ayaki, M.; Akedo, H. Y-27632, an inhibitor of rho-associated protein kinase, suppresses tumor cell invasion via regulation of focal adhesion and focal adhesion kinase. Jpn. J. Cancer Res. 2000, 91, 811-816.
-
(2000)
Jpn. J. Cancer Res
, vol.91
, pp. 811-816
-
-
Imamura, F.1
Mukai, M.2
Ayaki, M.3
Akedo, H.4
-
54
-
-
0036931306
-
Lysophosphatidic acid induces focal adhesion assembly through rho/rho-associated kinase pathway in human ovarian cancer cells
-
Sawada, K.; Morishige, K.; Tahara, M.; Ikebuchi, Y.; Kawagishi, R.; Tasaka, K.; Murata, Y. Lysophosphatidic acid induces focal adhesion assembly through rho/rho-associated kinase pathway in human ovarian cancer cells. Gynecol. Oncol. 2002, 87, 252-259.
-
(2002)
Gynecol. Oncol
, vol.87
, pp. 252-259
-
-
Sawada, K.1
Morishige, K.2
Tahara, M.3
Ikebuchi, Y.4
Kawagishi, R.5
Tasaka, K.6
Murata, Y.7
-
55
-
-
71349084410
-
The suppressive effect of rho kinase inhibitor, y-27632, on oncogenic ras/rhoa induced invasion/migration of human bladder cancer tsgh cells
-
Chang, H.R.; Huang, H.P.; Kao, Y.L.; Chen, S.L.; Wu, S.W.; Hung, T.W.; Lian, J.D.; Wang, C.J. The suppressive effect of rho kinase inhibitor, y-27632, on oncogenic ras/rhoa induced invasion/migration of human bladder cancer tsgh cells. Chem. Biol. Interact. 2010, 183, 172-180.
-
(2010)
Chem. Biol. Interact
, vol.183
, pp. 172-180
-
-
Chang, H.R.1
Huang, H.P.2
Kao, Y.L.3
Chen, S.L.4
Wu, S.W.5
Hung, T.W.6
Lian, J.D.7
Wang, C.J.8
-
56
-
-
0035874877
-
Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cdna microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the nf-kappab signal pathway
-
Dong, G.; Loukinova, E.; Chen, Z.; Gangi, L.; Chanturita, T.I.; Liu, E.T.; van Waes, C. Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cdna microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the nf-kappab signal pathway. Cancer Res. 2001, 61, 4797-4808.
-
(2001)
Cancer Res
, vol.61
, pp. 4797-4808
-
-
Dong, G.1
Loukinova, E.2
Chen, Z.3
Gangi, L.4
Chanturita, T.I.5
Liu, E.T.6
van Waes, C.7
-
57
-
-
0346751951
-
Pleiotropic effects of cxc chemokines in gastric carcinoma: Differences in cxcl8 and cxcl1 expression between diffuse and intestinal types of gastric carcinoma
-
Eck, M.; Schmausser, B.; Scheller, K.; Brandlein, S.; Muller-Hermelink, H.K. Pleiotropic effects of cxc chemokines in gastric carcinoma: Differences in cxcl8 and cxcl1 expression between diffuse and intestinal types of gastric carcinoma. Clin. Exp. Immunol. 2003, 134, 508-515.
-
(2003)
Clin. Exp. Immunol
, vol.134
, pp. 508-515
-
-
Eck, M.1
Schmausser, B.2
Scheller, K.3
Brandlein, S.4
Muller-Hermelink, H.K.5
-
58
-
-
3042638491
-
Growth-regulated oncogene-1 expression is associated with angiogenesis and lymph node metastasis in human oral cancer
-
Shintani, S.; Ishikawa, T.; Nonaka, T.; Li, C.; Nakashiro, K.; Wong, D.T.; Hamakawa, H. Growth-regulated oncogene-1 expression is associated with angiogenesis and lymph node metastasis in human oral cancer. Oncology 2004, 66, 316-322.
-
(2004)
Oncology
, vol.66
, pp. 316-322
-
-
Shintani, S.1
Ishikawa, T.2
Nonaka, T.3
Li, C.4
Nakashiro, K.5
Wong, D.T.6
Hamakawa, H.7
-
59
-
-
33645047391
-
Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer
-
Lee, Z.; Swaby, R.F.; Liang, Y.; Yu, S.; Liu, S.; Lu, K.H.; Bast, R.C., Jr.; Mills, G.B.; Fang, X. Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer. Cancer Res. 2006, 66, 2740-2748.
-
(2006)
Cancer Res
, vol.66
, pp. 2740-2748
-
-
Lee, Z.1
Swaby, R.F.2
Liang, Y.3
Yu, S.4
Liu, S.5
Lu, K.H.6
Bast Jr., R.C.7
Mills, G.B.8
Fang, X.9
-
60
-
-
0037131366
-
Identification of human plasma lysophospholipase d, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase
-
Tokumura, A.; Majima, E.; Kariya, Y.; Tominaga, K.; Kogure, K.; Yasuda, K.; Fukuzawa, K. Identification of human plasma lysophospholipase d, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J. Biol. Chem. 2002, 277, 39436-39442.
-
(2002)
J. Biol. Chem
, vol.277
, pp. 39436-39442
-
-
Tokumura, A.1
Majima, E.2
Kariya, Y.3
Tominaga, K.4
Kogure, K.5
Yasuda, K.6
Fukuzawa, K.7
-
61
-
-
1542359873
-
Autotaxin has lysophospholipase d activity leading to tumor cell growth and motility by lysophosphatidic acid production
-
Umezu-Goto, M.; Kishi, Y.; Taira, A.; Hama, K.; Dohmae, N.; Takio, K.; Yamori, T.; Mills, G.B.; Inoue, K.; Aoki, J.; et al. Autotaxin has lysophospholipase d activity leading to tumor cell growth and motility by lysophosphatidic acid production. J. Cell Biol. 2002, 158, 227-233.
-
(2002)
J. Cell Biol
, vol.158
, pp. 227-233
-
-
Umezu-Goto, M.1
Kishi, Y.2
Taira, A.3
Hama, K.4
Dohmae, N.5
Takio, K.6
Yamori, T.7
Mills, G.B.8
Inoue, K.9
Aoki, J.10
-
62
-
-
0035884290
-
Autotaxin (npp-2), a metastasis-enhancing motogen, is an angiogenic factor
-
Nam, S.W.; Clair, T.; Kim, Y.S.; McMarlin, A.; Schiffmann, E.; Liotta, L.A.; Stracke, M.L. Autotaxin (npp-2), a metastasis-enhancing motogen, is an angiogenic factor. Cancer Res. 2001, 61, 6938-6944.
-
(2001)
Cancer Res
, vol.61
, pp. 6938-6944
-
-
Nam, S.W.1
Clair, T.2
Kim, Y.S.3
McMarlin, A.4
Schiffmann, E.5
Liotta, L.A.6
Stracke, M.L.7
-
63
-
-
0034642507
-
Autotaxin (atx), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells
-
Nam, S.W.; Clair, T.; Campo, C.K.; Lee, H.Y.; Liotta, L.A.; Stracke, M.L. Autotaxin (atx), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells. Oncogene 2000, 19, 241-247.
-
(2000)
Oncogene
, vol.19
, pp. 241-247
-
-
Nam, S.W.1
Clair, T.2
Campo, C.K.3
Lee, H.Y.4
Liotta, L.A.5
Stracke, M.L.6
-
64
-
-
84866656014
-
Serum autotaxin is not a useful biomarker for ovarian cancer
-
Nakamura, K.; Igarashi, K.; Ohkawa, R.; Yokota, H.; Masuda, A.; Nakagawa, S.; Yano, T.; Ikeda, H.; Aoki, J.; Yatomi, Y. Serum autotaxin is not a useful biomarker for ovarian cancer. Lipids 2012, 47, 927-930.
-
(2012)
Lipids
, vol.47
, pp. 927-930
-
-
Nakamura, K.1
Igarashi, K.2
Ohkawa, R.3
Yokota, H.4
Masuda, A.5
Nakagawa, S.6
Yano, T.7
Ikeda, H.8
Aoki, J.9
Yatomi, Y.10
-
65
-
-
67650658819
-
Expression of autotaxin, an ectoenzyme that produces lysophosphatidic acid, in human placenta
-
Iwasawa, Y.; Fujii, T.; Nagamatsu, T.; Kawana, K.; Okudaira, S.; Miura, S.; Matsumoto, J.; Tomio, A.; Hyodo, H.; Yamashita, T.; et al. Expression of autotaxin, an ectoenzyme that produces lysophosphatidic acid, in human placenta. Am. J. Reprod. Immunol. 2009, 62, 90-95.
-
(2009)
Am. J. Reprod. Immunol
, vol.62
, pp. 90-95
-
-
Iwasawa, Y.1
Fujii, T.2
Nagamatsu, T.3
Kawana, K.4
Okudaira, S.5
Miura, S.6
Matsumoto, J.7
Tomio, A.8
Hyodo, H.9
Yamashita, T.10
-
66
-
-
77954489421
-
Low-density lipoprotein-cholesterol/high-density lipoprotein-cholesterol ratio predicts lipid-rich coronary plaque in patients with coronary artery disease-integrated-backscatter intravascular ultrasound study
-
Kimura, T.; Itoh, T.; Fusazaki, T.; Matsui, H.; Sugawara, S.; Ogino, Y.; Endo, H.; Kobayashi, K.; Nakamura, M. Low-density lipoprotein-cholesterol/high-density lipoprotein-cholesterol ratio predicts lipid-rich coronary plaque in patients with coronary artery disease-integrated-backscatter intravascular ultrasound study. Circ. J. 2010, 74, 1392-1398.
-
(2010)
Circ. J
, vol.74
, pp. 1392-1398
-
-
Kimura, T.1
Itoh, T.2
Fusazaki, T.3
Matsui, H.4
Sugawara, S.5
Ogino, Y.6
Endo, H.7
Kobayashi, K.8
Nakamura, M.9
-
67
-
-
34250770503
-
Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitisc
-
Watanabe, N.; Ikeda, H.; Nakamura, K.; Ohkawa, R.; Kume, Y.; Aoki, J.; Hama, K.; Okudaira, S.; Tanaka, M.; Tomiya, T.; et al. Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitisc. J. Clin. Gastroenterol. 2007, 41, 616-623.
-
(2007)
J. Clin. Gastroenterol
, vol.41
, pp. 616-623
-
-
Watanabe, N.1
Ikeda, H.2
Nakamura, K.3
Ohkawa, R.4
Kume, Y.5
Aoki, J.6
Hama, K.7
Okudaira, S.8
Tanaka, M.9
Tomiya, T.10
-
68
-
-
49949098676
-
Two pathways for lysophosphatidic acid production
-
Aoki, J.; Inoue, A.; Okudaira, S. Two pathways for lysophosphatidic acid production. Biochim. Biophys. Acta 2008, 1781, 513-518.
-
(2008)
Biochim. Biophys. Acta
, vol.1781
, pp. 513-518
-
-
Aoki, J.1
Inoue, A.2
Okudaira, S.3
-
69
-
-
51349135711
-
-
Phospholipase d activity regulates integrin-mediated cell spreading and migration by inducing gtp-rac translocation to the plasma membrane
-
Chae, Y.C.; Kim, J.H.; Kim, K.L.; Kim, H.W.; Lee, H.Y.; Heo, W.D.; Meyer, T.; Suh, P.G.; Ryu, S.H. Phospholipase d activity regulates integrin-mediated cell spreading and migration by inducing gtp-rac translocation to the plasma membrane. Mol. Biol. Cell. 2008, 19, 3111-3123.
-
(2008)
Mol. Biol. Cell
, vol.19
, pp. 3111-3123
-
-
Chae, Y.C.1
Kim, J.H.2
Kim, K.L.3
Kim, H.W.4
Lee, H.Y.5
Heo, W.D.6
Meyer, T.7
Suh, P.G.8
Ryu, S.H.9
-
70
-
-
0034083409
-
-
Constitutive Acid lysophosphatidic acid (LPA)-induced LPA production: Role of phospholipase d and phospholipase a2
-
Eder, A.M.; Sasagawa, T.; Mao, M.; Aoki, J.; Mills, G.B. Constitutive and lysophosphatidic acid (LPA)-induced LPA production: Role of phospholipase d and phospholipase a2. Clin. Cancer Res. 2000, 6, 2482-2491.
-
(2000)
Clin. Cancer Res
, vol.6
, pp. 2482-2491
-
-
Eder, A.M.1
Sasagawa, T.2
Mao, M.3
Aoki, J.4
Mills, G.B.5
-
71
-
-
78751518056
-
Dysregulation of sphingolipid metabolism in cancer
-
Ryland, L.K.; Fox, T.E.; Liu, X.; Loughran, T.P.; Kester, M. Dysregulation of sphingolipid metabolism in cancer. Cancer Biol. Ther 2011, 11, 138-149.
-
(2011)
Cancer Biol. Ther
, vol.11
, pp. 138-149
-
-
Ryland, L.K.1
Fox, T.E.2
Liu, X.3
Loughran, T.P.4
Kester, M.5
-
72
-
-
33748746334
-
When do lasses (longevity assurance genes) become cers (ceramide synthases)?: Insights into the regulation of ceramide synthesis
-
Pewzner-Jung, Y.; Ben-Dor, S.; Futerman, A.H. When do lasses (longevity assurance genes) become cers (ceramide synthases)?: Insights into the regulation of ceramide synthesis. J. Biol. Chem. 2006, 281, 25001-25005.
-
(2006)
J. Biol. Chem
, vol.281
, pp. 25001-25005
-
-
Pewzner-Jung, Y.1
Ben-Dor, S.2
Futerman, A.H.3
-
73
-
-
84860714751
-
Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids
-
Gatt, S.; Dagan, A. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids. Chem. Phys. Lipids 2012, 165, 462-474.
-
(2012)
Chem. Phys. Lipids
, vol.165
, pp. 462-474
-
-
Gatt, S.1
Dagan, A.2
-
74
-
-
0038641944
-
-
Killing tumours by ceramide-induced apoptosis: A critique of available drugs
-
Radin, N.S. Killing tumours by ceramide-induced apoptosis: A critique of available drugs. Biochem. J. 2003, 371, 243-256.
-
(2003)
Biochem. J
, vol.371
, pp. 243-256
-
-
Radin, N.S.1
-
75
-
-
0035114217
-
Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer
-
Selzner, M.; Bielawska, A.; Morse, M.A.; Rudiger, H.A.; Sindram, D.; Hannun, Y.A.; Clavien, P.A. Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Res. 2001, 61, 1233-1240.
-
(2001)
Cancer Res
, vol.61
, pp. 1233-1240
-
-
Selzner, M.1
Bielawska, A.2
Morse, M.A.3
Rudiger, H.A.4
Sindram, D.5
Hannun, Y.A.6
Clavien, P.A.7
-
76
-
-
0037030465
-
Ceramide induces mitochondrial activation and apoptosis via a bax-dependent pathway in human carcinoma cells
-
Von Haefen, C.; Wieder, T.; Gillissen, B.; Starck, L.; Graupner, V.; Dorken, B.; Daniel, P.T. Ceramide induces mitochondrial activation and apoptosis via a bax-dependent pathway in human carcinoma cells. Oncogene 2002, 21, 4009-4019.
-
(2002)
Oncogene
, vol.21
, pp. 4009-4019
-
-
von Haefen, C.1
Wieder, T.2
Gillissen, B.3
Starck, L.4
Graupner, V.5
Dorken, B.6
Daniel, P.T.7
-
77
-
-
77953303657
-
-
Sphingosine Kinase Mediates Resistance to The Synthetic Retinoid N-(4-hydroxyphenyl)retinamide In Human Ovarian Cancer Cells
-
Illuzzi, G.; Bernacchioni, C.; Aureli, M.; Prioni, S.; Frera, G.; Donati, C.; Valsecchi, M.; Chigorno, V.; Bruni, P.; Sonnino, S.; et al. Sphingosine kinase mediates resistance to the synthetic retinoid N-(4-hydroxyphenyl)retinamide in human ovarian cancer cells. J. Biol. Chem. 2010, 285, 18594-18602.
-
(2010)
J. Biol. Chem
, vol.285
, pp. 18594-18602
-
-
Illuzzi, G.1
Bernacchioni, C.2
Aureli, M.3
Prioni, S.4
Frera, G.5
Donati, C.6
Valsecchi, M.7
Chigorno, V.8
Bruni, P.9
Sonnino, S.10
-
78
-
-
52449092057
-
Targeting sphk1 as a new strategy against cancer
-
Shida, D.; Takabe, K.; Kapitonov, D.; Milstien, S.; Spiegel, S. Targeting sphk1 as a new strategy against cancer. Curr. Drug Targets 2008, 9, 662-673.
-
(2008)
Curr. Drug Targets
, vol.9
, pp. 662-673
-
-
Shida, D.1
Takabe, K.2
Kapitonov, D.3
Milstien, S.4
Spiegel, S.5
-
79
-
-
0033053652
-
-
Sphingosine 1-phosphate: A prototype of a new class of second messengers
-
Spiegel, S. Sphingosine 1-phosphate: A prototype of a new class of second messengers. J. Leukoc. Biol. 1999, 65, 341-344.
-
(1999)
J. Leukoc. Biol
, vol.65
, pp. 341-344
-
-
Spiegel, S.1
-
80
-
-
77954406077
-
-
Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry, doi:10.1186/1476-4598-9-186
-
Liu, Y.; Chen, Y.; Momin, A.; Shaner, R.; Wang, E.; Bowen, N.J.; Matyunina, L.V.; Walker, L.D.; McDonald, J.F.; Sullards, M.C.; et al. Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry. Mol. Cancer 2010, 9, doi:10.1186/1476-4598-9-186
-
(2010)
Mol. Cancer
, vol.9
-
-
Liu, Y.1
Chen, Y.2
Momin, A.3
Shaner, R.4
Wang, E.5
Bowen, N.J.6
Matyunina, L.V.7
Walker, L.D.8
McDonald, J.F.9
Sullards, M.C.10
-
81
-
-
1442274995
-
Sulfatides in ovarian tumors: Clinicopathological correlates
-
Makhlouf, A.M.; Fathalla, M.M.; Zakhary, M.A.; Makarem, M.H. Sulfatides in ovarian tumors: Clinicopathological correlates. Int J. Gynecol. Cancer 2004, 14, 89-93.
-
(2004)
Int J. Gynecol. Cancer
, vol.14
, pp. 89-93
-
-
Makhlouf, A.M.1
Fathalla, M.M.2
Zakhary, M.A.3
Makarem, M.H.4
-
82
-
-
76949086699
-
-
Lysophosphatidic acid assay in patients with ovarian cancer or who are at risk for ovarian cancer. (accessed on 17 January 2013)
-
ClinicalTrials.gov NCT00986206. Lysophosphatidic acid assay in patients with ovarian cancer or who are at risk for ovarian cancer. Available online: http://clinicaltrials.gov/show/NCT00986206 (accessed on 17 January 2013).
-
ClinicalTrials.gov NCT00986206
-
-
-
83
-
-
84867656708
-
Measurement of phospholipids may improve diagnostic accuracy in ovarian cancer
-
doi:10.1371/journal.pone.0046846
-
Shan, L.; Chen, Y.A.; Davis, L.; Han, G.; Zhu, W.; Molina, A.D.; Arango, H.; LaPolla, J.P.; Hoffman, M.S.; Sellers, T.; et al. Measurement of phospholipids may improve diagnostic accuracy in ovarian cancer. PLoS One 2012, 7, doi:10.1371/journal.pone.0046846
-
(2012)
PLoS One
, vol.7
-
-
Shan, L.1
Chen, Y.A.2
Davis, L.3
Han, G.4
Zhu, W.5
Molina, A.D.6
Arango, H.7
Lapolla, J.P.8
Hoffman, M.S.9
Sellers, T.10
-
84
-
-
84856849289
-
Cancer metabolism: Current perspectives and future directions
-
Munoz-Pinedo, C.; El Mjiyad, N.; Ricci, J.E. Cancer metabolism: Current perspectives and future directions. Cell. Death Dis. 2012, 3, doi:10.1038/cddis.2011.123
-
(2012)
Cell. Death Dis
, pp. 3
-
-
Munoz-Pinedo, C.1
El Mjiyad, N.2
Ricci, J.E.3
-
85
-
-
77951182123
-
Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: Potential therapeutic relevance
-
Martirosyan, A.; Clendening, J.W.; Goard, C.A.; Penn, L.Z. Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: Potential therapeutic relevance. BMC Cancer 2010, 10, doi:10.1186/1471-2407-10-103
-
(2010)
BMC Cancer
, pp. 10
-
-
Martirosyan, A.1
Clendening, J.W.2
Goard, C.A.3
Penn, L.Z.4
-
86
-
-
84876317585
-
-
A phase II study of interaction of lovastatin and paclitaxel for patients with refractory or relapsed ovarian cancer.(accessed on 16 January 2013).
-
ClinicalTrials.gov NCT00585052. A phase II study of interaction of lovastatin and paclitaxel for patients with refractory or relapsed ovarian cancer. Available online: http://clinicaltrials.gov/ show/NCT00585052 (accessed on 16 January 2013).
-
ClinicalTrials.gov NCT00585052
-
-
-
87
-
-
34250303805
-
Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer
-
Van Vlerken, L.E.; Duan, Z.; Seiden, M.V.; Amiji, M.M. Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer. Cancer Res. 2007, 67, 4843-4850.
-
(2007)
Cancer Res
, vol.67
, pp. 4843-4850
-
-
van Vlerken, L.E.1
Duan, Z.2
Seiden, M.V.3
Amiji, M.M.4
-
88
-
-
34249828179
-
Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs
-
Swanton, C.; Marani, M.; Pardo, O.; Warne, P.H.; Kelly, G.; Sahai, E.; Elustondo, F.; Chang, J.; Temple, J.; Ahmed, A.A.; et al. Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs. Cancer Cell 2007, 11, 498-512.
-
(2007)
Cancer Cell
, vol.11
, pp. 498-512
-
-
Swanton, C.1
Marani, M.2
Pardo, O.3
Warne, P.H.4
Kelly, G.5
Sahai, E.6
Elustondo, F.7
Chang, J.8
Temple, J.9
Ahmed, A.A.10
-
89
-
-
0347611095
-
Molecular machinery for non-vesicular trafficking of ceramide
-
Hanada, K.; Kumagai, K.; Yasuda, S.; Miura, Y.; Kawano, M.; Fukasawa, M.; Nishijima, M. Molecular machinery for non-vesicular trafficking of ceramide. Nature 2003, 426, 803-809.
-
(2003)
Nature
, vol.426
, pp. 803-809
-
-
Hanada, K.1
Kumagai, K.2
Yasuda, S.3
Miura, Y.4
Kawano, M.5
Fukasawa, M.6
Nishijima, M.7
-
90
-
-
77949915910
-
Autotaxin delays apoptosis induced by carboplatin in ovarian cancer cells
-
Vidot, S.; Witham, J.; Agarwal, R.; Greenhough, S.; Bamrah, H.S.; Tigyi, G.J.; Kaye, S.B.; Richardson, A. Autotaxin delays apoptosis induced by carboplatin in ovarian cancer cells. Cell Signal. 2010, 22, 926-935.
-
(2010)
Cell Signal
, vol.22
, pp. 926-935
-
-
Vidot, S.1
Witham, J.2
Agarwal, R.3
Greenhough, S.4
Bamrah, H.S.5
Tigyi, G.J.6
Kaye, S.B.7
Richardson, A.8
|